Skip to main content
    • Aa
    • Aa

Comparative and quantitative investigation of cell labeling of a 12-nm DMSA-coated Fe3O4 magnetic nanoparticle with multiple mammalian cell lines

  • Yingxun Liu (a1) and Jinke Wang (a1)

This work investigated the cell labeling of 12-nm meso-2,-3-dimercaptosuccinic acid (DMSA)-coated Fe3O4 magnetic nanoparticles with multiple mammalian cells. Six different cells, including RAW264.7, Hepa1-6, THP-1, HepG2, HeLa, and HL-7702, were treated with the nanoparticles at various concentrations (20~100 μg/mL) for different times (2~72 h), and the labeling effect was evaluated by observing the intracellular internalization of the nanoparticles with Prussian blue staining and measuring the corresponding cellular iron loading with colorimetric assay. The results demonstrated that the nanoparticles could label all cells studied. However, the labeling efficiency was not the same between different cells, which depended on the cell types, the nanoparticles’ concentration, and the time of treating cells with the nanoparticles. In comparison, RAW264.7 was labeled more effectively than other cells at any concentration of the nanoparticles. The iron loading of RAW264.7 significantly increased with the concentration of the nanoparticles and the treatment time. However, both human liver cells (HepG2 and HL-7720) were labeled with the lowest iron loading. The measurement of cell viability revealed that the growth of all cells was not affected by the nanoparticles at a common in vivo application dose of iron nanoparticles (30 μg/mL), demonstrating that the nanoparticles have better biocompatability.

Corresponding author
a)Address all correspondence to this author. e-mail:
Hide All
1.Shaw S.Y., Westly E.C., Pittet M.J., Subramanian A., Schreiber S.L., and Weissleder R.: Perturbational profiling of nanomaterial biologic activity. Proc. Natl. Acad. Sci. USA 105, 7387 (2008).
2.Miller M.M., Prinz G.A., Cheng S.F., and Bounnak S.: Detection of a micron-sized magnetic sphere using a ring-shaped anisotropic magnetoresistance-based sensor: A model for a magnetoresistance-based biosensor. Appl. Phys. Lett. 81, 2211 (2002).
3.Jain T.K., Morales M.A., Sahoo S.K., Leslie-Pelecky D.L., and Labhasetwar V.: Iron oxide nanoparticles for sustained delivery of anticancer agents. Mol. Pharm. 2, 194 (2005).
4.Chourpa I., Douziech-Eyrolles L., Ngaboni-Okassa L., Fouquenet J.F., Cohen-Jonathan S., Souce M., Marchais H., and Dubois P.: Molecular composition of iron oxide nanoparticles, precursors for magnetic drug targeting, as characterized by confocal Raman microspectroscopy. Analyst (Lond.) 130, 1395 (2005).
5.Tiefenauer L.X.: Magnetic nanoparticles as contrast agents for medical diagnosis in nanotechnology, in Biology and Medicine: Methods, Devices, and Applications, edited by Vo-Dinh T. (CRC Press, Taylor and Francis, Boca Raton, FL, 2007), pp. 120.
6.Morana G., Salviato E., and Guarise A.: Contrast agents for hepatic MRI. Cancer Imaging 7(Special issue A), S24 (2007).
7.Modo M.M.J. and Bulteì J.W.M.: Molecular and Cellular MR Imaging (CRC Press, Boca Raton, FL, 2007).
8.Corot C., Robert P., Idee J.M., and Port M.: Recent advances in iron oxide nanocrystal technology for medical imaging. Adv. Drug Delivery Rev. 58, 1471 (2006).
9.Ito A., Shinkai M., Honda H., and Kobayashi T.: Heat-inducible TNF-alpha gene therapy combined with hyperthermia using magnetic nanoparticles as a novel tumor-targeted therapy. Cancer Gene Ther. 8, 649 (2001).
10.Hergt R. and Dutz S.: Magnetic particle hyperthermia-biophysical limitations of a visionary tumour therapy. J. Magn. Magn. Mater. 311, 187 (2007).
11.Nam H.Y., Kwon S.M., Chung H., Lee S.Y., Kwon S.H., Jeon H., Kim Y., Park J.H., Kim J., Her S., Oh Y.K., Kwon I.C., Kim K., and Jeong S.Y.: Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles. J. Controlled Release 135, 259 (2009).
12.Chithrani B.D., Ghazani A.A., and Chan W.C.: Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 6, 662 (2006).
13.Chen Z.P., Zhang Y., Zhang S., Xia J.G., Liu J.W., Xu K., and Gu N.: Preparation and characterization of water-soluble monodisperse magnetic iron oxide nanoparticles via surface double-exchange with DMSA. Colloids Surf., A: 316, 210 (2008).
14.Pieters R., Huismans D.R., Leyva A., and Veerman A.J.P.: Comparison of the rapid automated MTT-assay with a dye exclusion assay for chemosensitivity testing in childhood leukaemia. Br. J. Cancer 59, 217 (1989).
15.Häfeli U.O., Riffle J.S., Harris-Shekhawat L., Carmichael-Baranauskas A., Mark F., Dailey J.P., and Bardenstein D.: Cell uptake and in vitro toxicity of magnetic nanoparticles suitable for drug delivery. Mol. Pharm. 6, 1417 (2009).
16.Wilhelm C., Billotey C., Roger J., Pons J.N., Bacri J.C., and Gazeau F.: Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating. Biomaterials 24, 1001 (2003).
17.Wilhelm C., Gazeau F., Roger J., Pons J.N., and Bacri J.C.: Interaction of anionic superparamagnetic nanoparticles with cells: Kinetic analyses of membrane adsorption and subsequent internalization. Langmuir 18, 8148 (2002).
18.Wilhelm C. and Gazeau F.: Universal cell labelling with anionic magnetic nanoparticles. Biomaterials 29, 3161 (2008).
19.Zhou J., Leuschner C., Kumar C., Hormes J., and Soboyejo W.O.: A TEM study of functionalized magnetic nanoparticles targeting breast cancer cells. Mater. Sci. Eng., C: Biomim. Supramol. Syst. 26, 1451 (2006).
20.Arbab A.S., Bashaw L.A., Miller B.R., Jordan E.K., Lewis B.K., Kalish H., and Frank J.A.: Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology 229, 838 (2003).
21.Frank J.A., Miller B.R., Arbab A.S., Zywicke H.A., Jordan E.K., Lewis B.K., Bryant L.H., and Bulte J.W.M. Jr: Clinically applicable labeling of mammalian cells and stem cells by combining superparamagnetic iron oxides and commonly available transfection agents. Radiology 228, 480 (2003).
22.Rivière C., Boudghène F.P., Gazeau F., Roger J., Pons J.N., Laissy J.P., Allaire E., Michel J.B., Letourneur D., and Deux J.F.: Iron oxide nanoparticle–labeled rat smooth muscle cells: Cardiac MR imaging for cell graft monitoring and quantitation. Radiology 235, 959 (2005).
23.Ju S.H., Teng G.J., Zhang Y., Ma M., Chen F., and Ni Y.Y.: In vitro labeling and MRI of mesenchymal stem cells from human umbilical cord blood. Magn. Reson. Imaging 24, 611 (2006).
24.Song M., Moon W.K., Kim Y., Lim D., Song I.C., and Yoon B.W.: Labeling efficacy of superparamagnetic iron oxide nanoparticles to human neural stem cells: Comparison of ferumoxides, monocrystalline iron oxide, cross-linked iron oxide (CLIO)-NH2 and tat-CLIO. Korean J. Radiol. 8, 365 (2007).
25.Schwarz S., Fernandes F., Sanroman L., Hodenius M., Lang C., Himmelreich U., Schmitz-Rode T., Schueler D., Hoehn M., Zenke M., and Hieronymus T.: Synthetic and biogenic magnetite nanoparticles for tracking of stem cells and dendritic cells. J. Magn. Magn. Mater. 321, 1533 (2009).
26.Farrell E., Wielopolski P., Pavljasevic P., Kops N., Weinans H., Bernsen M.R., and van Osch G.J.: Cell labelling with superparamagnetic iron oxide has no effect on chondrocyte behaviour. Osteoarthritis Cartilage 17, 961 (2009).
27.Slavin W.: Atomic absorption spectrometry. Methods Enzymol. 158, 117 (1988).
28.Hoepken H.H., Korten T., Robinson S.R., and Dringen R.: Iron accumulation, iron-mediated toxicity and altered levels of ferritin and transferrin receptor in cultured astrocytes during incubation with ferric ammonium citrate. J. Neurochem. 88, 1194 (2004).
29.Woodmansee A.N. and Imlay J.A.: Quantitation of intracellular free iron by electron paramagnetic resonance spectroscopy. Methods Enzymol. 349, 3 (2002).
30.Strom V., Hultenby K., Gruttner C., Teller J., Xu B., and Holgersson J.: A novel and rapid method for quantification of magnetic nanoparticle–cell interactions using a desktop susceptometer. Nanotechnology 15, 457 (2004).
31.LeVine S.M., Wulser M.J., and Lynch S.G.: Iron quantification in cerebrospinal fluid. Anal. Biochem. 265, 74 (1998).
32.Fish W.W.: Rapid colorimetric micromethod for the quantitation of complexed iron in biological samples. Methods Enzymol. 158, 357 (1988).
33.Adams P.E.: Determining iron content in foods by spectrophotometry. J. Chem. Educ. 72, 649 (1995).
34.Gay C., Collins J., and Gebicki J.M.: Determination of iron in solutions with the ferric-xylenol orange complex. Anal. Biochem. 27, 143 (1999).
35.Kalambur V.S., Longmire E.K., and Bischof J.C.: Cellular level loading and heating of superparamagnetic iron oxide nanoparticles. Langmuir 23, 12329 (2007).
36.Huberman A. and Perez C.: Nonheme iron determination. Anal. Biochem. 307, 375 (2002).
37.Rad A.M., Janic B., Iskander A.S.M., Soltanian-Zadeh H., and Arbab A.S.: Measurement of quantity of iron in magnetically labeled cells: Comparison among different UV/VIS spectrometric methods. Biotechniques 43, 627 (2007).
38.Jordan A., Scholz R., Wust P., Schirra H., Schiestel T., Schmidt H., and Felix R.: Endocytosis of dextran and silan-coated magnetite nanoparticles and the effect of intracellular hyperthermia on human mammary carcinoma cells in vitro. J. Magn. Magn. Mater. 194, 185 (1999).
39.Ho V.H.B., Barcza A., Chen R., Müller K.H., Darton N.J., and Slater N.K.H.: The precise control of cell labelling with streptavidin paramagnetic particles. Biomaterials 30, 6548 (2009).
40.Harisinghani M.G., Barentsz J., Hahn P.F., Deserno W.M., Tabatabaei S., van de Kaa C.H., de la Rosette J., and Weissleder R.: Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N. Engl. J. Med. 348, 2491 (2003).
41.Bacon B.R., Stark D.D., Park C.H., Saini S., Groman E.V., Hahn P.F., Compton C.C., and Ferrucci J.T.: Ferrite particles: A new magnetic resonance imaging contrast agent. Lack of acute or chronic hepatotoxicity after intravenous administration. J. Lab. Clin. Med. 110, 164 (1987).
42.Weissleder R., Stark D.D., Engelstad B.L., Bacon B.R., Compton C.C., White D.L., Jacobs P., and Lewis J.: Superparamagnetic iron oxide: Pharmacokinetics and toxicity. AJR Am. J. Roentgenol. 152, 167 (1989).
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Journal of Materials Research
  • ISSN: 0884-2914
  • EISSN: 2044-5326
  • URL: /core/journals/journal-of-materials-research
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Full text views

Total number of HTML views: 2
Total number of PDF views: 4 *
Loading metrics...

Abstract views

Total abstract views: 63 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 22nd October 2017. This data will be updated every 24 hours.